【24h】

Renal replacement therapy in the patient with acute brain injury.

机译:急性脑损伤患者的肾脏替代治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

The patient with an acute brain injury requiring renal replacement therapy presents a major problem in that conventional intermittent hemodialysis may exacerbate the injury by compromising cerebral perfusion pressure, either after a reduction in cerebral perfusion or because of increased cerebral edema. Compared with standard intermittent hemodialysis, the continuous forms of renal replacement therapy (CRRT) provide an effective therapy in terms of solute clearance, coupled with improved cardiovascular and intracranial stability. The disadvantage of CRRT is that anticoagulation may be required, and anticoagulants with systemic effects may provoke intracerebral hemorrhage, either at the site of damage or around the intracranial pressure monitoring device. Although peritoneal dialysis does not require anticoagulation, the clearances achieved are often less than those of CRRT, and sudden changes in intraperitoneal volume may provoke cardiovascular and thus intracranial instability.
机译:患有急性脑损伤的患者需要肾脏替代治疗,这是一个主要问题,因为常规的间歇性血液透析可能会通过降低脑灌注压力或由于脑水肿增加而损害脑灌注压力,从而加剧损伤。与标准的间歇性血液透析相比,肾脏替代疗法(CRRT)的连续形式在溶质清除方面提供了有效的疗法,并具有改善的心血管和颅内稳定性。 CRRT的缺点是可能需要抗凝药,并且具有全身作用的抗凝药可能会在损伤部位或颅内压监测装置周围引起脑内出血。尽管腹膜透析不需要抗凝治疗,但清除率通常比CRRT低,并且腹膜内体积的突然变化可能引起心血管疾病,从而引起颅内不稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号